Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective

Moura, AL; Pereira, C; Regateiro, FS; Azevedo, J; Todo Bom, A; Carrapatoso, I

http://hdl.handle.net/10400.4/2354

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
volume-sublingual-immunotherapy-ultrarush-protocol-safe-3211allasp1.pdf		102.28 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

Introduction. Sublingual immunotherapy (SLIT) with Pru p 3 can prevent severe allergic reactions to LTP-containing foods, but the standard initiation protocol is time-consuming. Objectives. Establish the safety of a novel ultra-rush initiation protocol for SLIT with Pru p 3. Methods. Prospective study comparing the side effects of the standard vs novel ultra-rush initiation protocols of SLIT with Pru p 3 in patients with anaphylaxis to LTP. Results. Fifteen patients were included (standard initiation, 5; ultra-rush initiation, 10), 80% females. All patients had oropharyngeal pruritus during initiation, 80% with spontaneous recovery, but no other gastro-intestinal, respiratory, cutaneous or systemic side effects occurred in any patient of both groups. Conclusion. The novel ultra-rush protocol halved the build-up time without increasing side effects.